CD85j / LILRB1 Rekombinanter Antikörper
CD85j / LILRB1 Rekombinant Antikörper für FC
Wirt / Isotyp
Maus / IgG2a
Getestete Reaktivität
human
Anwendung
FC
Konjugation
Unkonjugiert
CloneNo.
GHI/75
Kat-Nr. : 65623-1-MR
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in FC | humane PBMCs |
Empfohlene Verdünnung
| Anwendung | Verdünnung |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Produktinformation
65623-1-MR bindet in FC CD85j / LILRB1 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Maus / IgG2a |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Human Hairy Cell Leukemia Spleen Cells |
| Vollständiger Name | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
| Berechnetes Molekulargewicht | 71 kDa |
| GenBank-Zugangsnummer | BC015731 |
| Gene symbol | LILRB1 |
| Gene ID (NCBI) | 10859 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS with 0.09% sodium azide |
| Lagerungsbedingungen | Store at 2-8°C. Stable for one year after shipment. |
Hintergrundinformationen
LILRB1, also named as CD85j or ILT2, includes four C2 Ig domains binding HLA class I molecules in the extracellular region and a cytoplasmic domain containing four immunoreceptor tyrosine-based inhibition motifs (ITIM). LILRB1 is a surface glycoprotein detected on the surface of B cells, monocytes, dendritic cells, T cells and NK cells.
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| FC protocol for CD85j / LILRB1 antibody 65623-1-MR | Download protocol |
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |

